Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Design, Synthesis, and Anti-Hiv-1 Evaluation of a Novel Series of 1,2,3,4-Tetrahydropyrimidine-5-Carboxylic Acid Derivatives Publisher Pubmed



Sepehri S1, 2 ; Soleymani S3 ; Zabihollahi R3 ; Aghasadeghi MR3 ; Sadat M3 ; Saghaie L1 ; Memarian HR4 ; Fassihi A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran
  2. 2. Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, 5618953141, Iran
  3. 3. Department of Hepatitis and AIDS, Pasteur Institute of Iran, No. 69, Pasteur Ave, Tehran, 13169-43551, Iran
  4. 4. Department of Chemistry, Faculty of Sciences, University of Isfahan, Isfahan, 81746-73441, Iran

Source: Chemistry and Biodiversity Published:2018


Abstract

A series of tetrahydropyrimidine derivatives (2a – 2l) were designed, synthesized, and screened for anti-HIV-1 properties based on the structures of HIV-1 gp41 binding site inhibitors, NB-2 and NB-64. A computational study was performed to predict the pharmacodynamics, pharmacokinetics, and drug-likeness features of the studied molecules. Docking studies revealed that the carboxylic acid group in the molecules forms salt bridges with either Lys574 or Arg579. Physiochemical properties (e.g., molecular weight, number of hydrogen bond donors, number of hydrogen bond acceptors, and number of rotatable bonds) of the synthesized compounds confirmed and exhibited that these compounds were within the range set by Lipinski's rule of five. Compounds 2e and 2k with 4-chlorophenyl substituent and 4-methylphenyl group at C(4) position of the tetrahydropyrimidine ring was the most potent one among the tested compounds. This suggests that these compounds may serve as leads for development of novel small-molecule HIV-1 inhibitors. © 2018 Wiley-VHCA AG, Zurich, Switzerland
Related Docs
View other Related Docs
1. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 4-[4-Arylpyridin-1(4H)-Yl]Benzoic Acid Derivatives As Anti-Hiv-1 Agents, Chemistry and Biodiversity (2017)
2. Synthesis, Molecular Docking and Molecular Dynamics Simulation of 2- Thioxothiazolidin-4-One Derivatives Against Gp41, Current HIV Research (2020)
3. Novel 2-Alkylthio-1-Benzylimidazole-5-Carboxylic Acid Derivatives Targeting Gp41: Design, Synthesis, and in Vitro Anti-Hiv Activity Evaluation, Current HIV Research (2022)
4. Gp41 Inhibitory Activity Prediction of Theaflavin Derivatives Using Ligand/Structure-Based Virtual Screening Approaches, Computational Biology and Chemistry (2019)
5. Qsar and Docking Studies of Some 1,2,3,4-Tetrahydropyrimidines: Evaluation of Gp41 As Possible Target for Anti-Hiv-1 Activity, Medicinal Chemistry Research (2015)
6. Synthesis, Molecular Modelling and Biological Studies of 3-Hydroxy-Pyrane-4-One and 3-Hydroxy-Pyridine-4-One Derivatives As Hiv-1 Integrase Inhibitors, Medicinal Chemistry (2019)
7. Evaluation of the in Vitro Antiretroviral Potential of Some Biginelli-Type Pyrimidines, Acta Virologica (2012)
8. Identification of Novel 3-Hydroxy-Pyran-4-One Derivatives As Potent Hiv-1 Integrase Inhibitors Using in Silico Structure-Based Combinatorial Library Design Approach, Frontiers in Chemistry (2019)
Experts (# of related papers)
View all Related Experts
Afshin Fassihi (22)
Lotfollah Saghaie Dehkordi (13)
Other Related Docs
9. Design, Synthesis and Anti-Hiv-1 Evaluation of a Series of 5-Hydroxypyridine-4-One Derivatives As Possible Integrase Inhibitors, Medicinal Chemistry Research (2015)
10. Synthesis, Biological Evaluation and Molecular Docking Study of Dihydropyrimidine Derivatives As Potential Anticancer Agents, Journal of Heterocyclic Chemistry (2020)
11. Docking Studies of Some 5-Hydroxypyridine-4-One Derivatives: Evaluation of Integrase and Ribonuclease H Domain of Reverse Transcriptase As Possible Targets for Anti-Hiv-1 Activity, Medicinal Chemistry Research (2015)
12. Synthesis, Anti-Hiv-1 and Antiproliferative Evaluation of Novel 4-Nitroimidazole Derivatives Combined With 5-Hydroxy-4-Pyridinone Moiety, Journal of Molecular Structure (2020)
13. Anti-Hiv-1 Activity Prediction of Novel Gp41 Inhibitors Using Structure-Based Virtual Screening and Molecular Dynamics Simulation, Molecular Informatics (2017)
14. Synthesis, Antileishmanial Activity and Molecular Docking Study of a Series of Dihydropyridine Derivatives, Polycyclic Aromatic Compounds (2023)
15. Conformational Properties of Novel 1,2,3,4-Tetrahydropyrimidinone (Thione) Derivatives: A Dft Study, Journal of Reports in Pharmaceutical Sciences (2012)
16. Hantzsch-Type Dihydropyridines and Biginelli-Type Tetrahydropyrimidines: A Review of Their Chemotherapeutic Activities, Journal of Pharmacy and Pharmaceutical Sciences (2015)
17. In Silico Interactions of Some of the Triazole Derivatives With the Main Protease of Coronavirus, Biointerface Research in Applied Chemistry (2023)
18. Triterpene Constituents of Euphorbia Erythradenia Bioss. and Their Anti-Hiv Activity, Iranian Journal of Pharmaceutical Research (2016)
19. Halogenated Derivatives of Cytidine: Structural Analysis and Binding Affnity, Journal of Theoretical and Computational Chemistry (2020)
20. Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments, Research in Pharmaceutical Sciences (2020)
21. Synthesis, Biological Activity Evaluation, Docking and Molecular Dynamics Studies of New Triazole-Tetrahydropyrimidinone(Thione) Hybrid Scaffolds As Urease Inhibitors, Chemistry and Biodiversity (2023)
22. Quantitative Structure-Activity Relationship Studies on 2-Amino-6-Arylsulfonylbenzonitriles As Human Immunodeficiency Viruses Type 1 Reverse Transcriptase Inhibitors Using Descriptors Obtained From Substituents and Whole Molecular Structures, Chemical Biology and Drug Design (2009)
23. Qsar Study of Pett Derivatives As Potent Hiv-1 Reverse Transcriptase Inhibitors, Journal of Molecular Graphics and Modelling (2009)
24. Inhibitory Effect and Structure-Activity Relationship of Some Biginelli-Type Pyrimidines Against Hsv-1, Medicinal Chemistry Research (2013)
25. Hiv-1 Entry Inhibitors: A Review of Experimental and Computational Studies, Chemistry and Biodiversity (2018)
26. Homology Modeling of Human Ccr5 and Analysis of Its Binding Properties Through Molecular Docking and Molecular Dynamics Simulation, Biochimica et Biophysica Acta - Biomembranes (2011)
27. Introducing a Frameshift Mutation to the Pol Sequence of Hiv-1 Provirus and Evaluation of the Immunogenic Characteristics of the Mutated Virions (Rinnl4-3), Molecular Biology (2012)
28. Antimicrobial Evaluation of Some Novel Derivatives of 3,4- Dihydropyrimidine-2(1H)-One, Research in Pharmaceutical Sciences (2012)
29. Design and Synthesis of Novel Phe-Phe Hydroxyethylene Derivatives As Potential Coronavirus Main Protease Inhibitors, Journal of Biomolecular Structure and Dynamics (2022)
30. Synthesis and Biological Evaluation of Tetrahydropyrimidine and Dihydropyridine Derivatives Against Leishmania Major, Acta Parasitologica (2022)
31. Synthesis, Biological Assessment, and Computational Investigations of Nifedipine and Monastrol Analogues As Anti-Leishmanial Major and Anti-Microbial Agents, Molecular Diversity (2023)
32. Effect of Biomolecular Conformation on Docking Simulation: A Case Study on a Potent Hiv-1 Protease Inhibitor, Iranian Journal of Pharmaceutical Research (2015)
33. Computational Evaluation of Some Indenopyrazole Derivatives As Anticancer Compounds; Application of Qsar and Docking Methodologies, Journal of Enzyme Inhibition and Medicinal Chemistry (2013)
34. Design, Synthesis and Molecular Docking Studies of Some Tetrahydropyrimidine Derivatives As Possible Fascin Inhibitors, Chemistry and Biodiversity (2019)
35. Novel Aldimine-Type Schiff Bases of 4-Amino-5-[(3,4,5-Trimethoxyphenyl)Methyl]-1,2,4-Triazole-3-Thione/Thiol: Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity, Archiv der Pharmazie (2016)